KBC Securities - ENERGYVISION (ENRGY) Morning Notes : ENRGY BB

Report

KBC Securities

Hilde Van Boxstael ...

Wim Lewi

Morning Notes : ENRGY BB

: ENRGY BB

15/09/2025 1 EN

Underlying

ENERGYVISION

See profile

BE0974499312 Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Wim Lewi

Other Reports on these Companies

KBC Securities

Morning Notes : FAGR BB, IVA FP, SOF BB, ENRGY BB

: FAGR BB, IVA FP, SOF BB, ENRGY BB

October 9, 2025 October 9, 2025 1 EN

KBC Securities

Morning Notes : BREB BB, OPTI BB, EXM BB, SOLB BB, WDP BB, DEME BB, JDEP NA, ENRGY BB

: BREB BB, OPTI BB, EXM BB, SOLB BB, WDP BB, DEME BB, JDEP NA, ENRGY BB

September 19, 2025 September 19, 2025 1 EN

Solvay FIRST LOOK: 3Q underl. EBITDA supported by sale of CO2 emission rights

3Q underlying EBITDA was 12% better than our forecast and 14% above consensus but was supported by the sale of CO2 emission rights. Excluding this impact, 3Q underlying EBITDA would have been 8% below our forecast and 5% below consensus. Whilst future sales of CO2 emission rights are a possibility, this will mainly depend on future soda ash production levels in Europe and the overall competitive pressures within the soda ash market. Solvay reiterated the FY25 underlying EBITDA guidance of € 880-930m. Solvay also maintained FCF guidance of c. € 300m which however still means that almost all FCF...

1h / 39m 1h / 39m 1 EN

Guy Sips ... (+8)

Guy Sips
Hilde Van Boxstael
Jacob Mekhael
Lynn Hautekeete
Thibault Leneeuw
Thomas Couvreur
Wim Hoste
Wim Lewi

Morning Notes : AED BB, COFB BB, GLPG NA, JEN BB, SOLB BB, VGP BB, SHUR BB, CTPNV NA, IMCD NA, SYENS BB

: AED BB, COFB BB, GLPG NA, JEN BB, SOLB BB, VGP BB, SHUR BB, CTPNV NA, IMCD NA, SYENS BB

1h / 43m 1h / 43m 1 EN

Jacob Mekhael

Jacob Mekhael

Galapagos 9M25 results hold no surprises, new outlook following cell Tx winddown

Galapagos reported 9M25 results with a cash position of € 3,050m (YE24: € 3,317.8m) and an updated outlook, where it expects to end FY25 with € 2,975- € 3,025m in cash, and to incur costs of € 250-325m related to the winddown of the cell therapy business. Looking ahead, the company will focus its strategy on building a new pipeline through BD, and more information on BD strategy will be provided during this afternoon's conference call. € 37 TP and ACCUMULATE maintained.

2h / 13m 2h / 13m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : ENRGY BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : FAGR BB, IVA FP, SOF BB, ENRGY BB

Morning Notes : BREB BB, OPTI BB, EXM BB, SOLB BB, WDP BB, DEME BB, JDEP NA, ENRGY BB

Solvay FIRST LOOK: 3Q underl. EBITDA supported by sale of CO2 emission rights

Morning Notes : AED BB, COFB BB, GLPG NA, JEN BB, SOLB BB, VGP BB, SHUR BB, CTPNV NA, IMCD NA, SYENS BB

Galapagos 9M25 results hold no surprises, new outlook following cell Tx winddown

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe